Sermorelin + Ipamorelin
Not FDA approvedGrowth hormone secretagogue blend
Very thin human evidence
- Regulatory standing. Sold as a research chemical, not approved
- Anecdotal. Community reports, no controlled data
- No registered human trials. Nothing registered on ClinicalTrials.gov
- No sources. Nothing cited to verify
Computed with the same four public criteria as every profile. The human-evidence grade on an indexed profile is set automatically and may change when it is hand-reviewed. It is not a safety score, not a purity rating, and not medical advice, and not a claim that this compound treats, cures, or prevents any condition.
What it is
This is a combination of two separate peptides, sermorelin and ipamorelin, sold together as a blend. Sermorelin is a shortened analog of growth hormone releasing hormone that acts on the pituitary's GHRH receptor, and ipamorelin is a synthetic ghrelin receptor agonist. Both are thought to prompt the body to release more of its own growth hormone through different pathways.
What the evidence shows
The blend itself is not FDA-approved, and no registered human trials or published studies of this specific combination were identified. Each component has some separate human research, as sermorelin was once an approved diagnostic product that was later discontinued and ipamorelin reached early clinical trials, but whether the combination is safe or offers any benefit in humans is unclear.
What is in this blend
A blend is scored on its own, but the evidence for each ingredient lives on its own profile. Mixing compounds adds unknowns that none of the individual studies cover.
Sources
Risks, side effects and study doses are only published on hand-reviewed profiles. Want this one reviewed, or spotted something wrong? Tell us.